Lviv University Herald Series Psychological sciences
October 12, 2026
Ruslan Hanushchak, Игорь Прись
У статті здійснено ретроспективний огляд розвитку психоделічної терапії та проаналізовано сучасний стан досліджень її ефективності у лікуванні психічних розладів. Простежено еволюцію використання психоделічних речовин – від традиційних духовних і лікувальних практик корінних народів через ранні клінічні дослідження середини ХХ століття до сучасного етапу, так званого «психоделічного ренесансу»....
Psychiatry and Clinical Psychopharmacology
October 11, 2026
Kim Supit, Giordano N. Rossi, José Augusto S. Reis et al.
Background: Classic psychedelics, including LSD, psilocybin, and N,N-dimethyltryptamine (DMT)/ ayahuasca, have shown promise as rapid-acting treatments for psychiatric disorders. Because sleep plays a central role in emotional regulation and neuroplasticity, psychedelic-induced changes in sleep architecture are of interest.Methods: A systematic review was conducted following PRISMA guidelines....
Cortica
October 10, 2026
Ayla Gay
Altered states of consciousness (ASCs) induced by psychological practices (mindfulness meditation, hypnosis, self-induced trance) and pharmacological agents (classical and atypical psychedelics) are increasingly linked to therapeutic change, yet their shared and unique neural signatures remain uncertain. We conducted three preregistered, coordinate-based meta-analyses using SDM-PSI, mindfulness...
Surgical Neurology International
October 9, 2026
Andrea Garcia-Bitar, Eduardo Jesus Castañeda, José Rafael Buenrostro-Rangel et al.
Background: Neurosurgical patients carry a high and frequently undertreated burden of psychological suffering, acute and chronic pain, and neurological deficits amenable to recovery. The resurgence of psychedelic research has produced relevant evidence in adjacent fields, but its applicability to neurosurgery has not been systematized. This review synthesizes that evidence across prevention,...
Journal of Psychopharmacology
September 22, 2026
Maria Niedernhuber, Dila Suay, Bigna Lenggenhager et al.
BACKGROUND: Psychoactive serotonin 5-HT2A receptor agonists are potent modulators of awareness. Influential theories propose that psychedelics alter whole-brain dynamics by increasing neural signal diversity and dynamic flexibility. Beyond temporal variability, it is an open question whether psychedelics impact the characteristics of transient neural state sequences themselves. AIMS: Our goal...
npj Mental Health Research
September 17, 2026
U. Lueken, Isabel Dziobek, Martha N. Havenith et al.
High ventilation breathwork (HVB) can induce altered states of consciousness with phenomenological similarities to those reported following administration of serotonergic psychedelics such as lysergic acid diethylamide (LSD), psilocybin or ayahuasca. Non-pharmacological methods capable of reliably eliciting such states may provide scalable models for investigating therapeutic mechanisms...
Revista JRG de Estudos Acadêmicos
September 16, 2026
Monique Vieira de Moura, Heder Albuquerque Azevedo Rocha, Márcio José de Carvalho Lima et al.
A depressão resistente ao tratamento (DRT) representa uma condição de elevada carga clínica e funcional, usualmente definida pela resposta inadequada a pelo menos dois tratamentos antidepressivos adequados. O interesse por psicodélicos clássicos ressurgiu diante da possibilidade de efeitos antidepressivos rápidos após uma ou poucas administrações em contexto supervisionado. O objetivo desta...
Applied Drug Research Clinical Trials and Regulatory Affairs
September 14, 2026
A S Shikha, Jignesh Shah, Darshil B. Shah et al.
Introduction: Psychedelic-assisted therapy has resurfaced as a promising intervention for treatment-resistant psychiatric disorders. However, regulatory pathways differ considerably across countries because of social, ethical, legal, and political factors. Methods: This review was conducted using the regulatory frameworks of Australia, Brazil, and the USA, along with publicly accessible data,...
Orvosi hetilap
September 13, 2026
Szabolcs Kéri
Over the past five years, the literature on the psychiatric use of psychedelic and related treatments has expanded substantially. Several randomized controlled trials and pooled analyses have been conducted in mood disorders, treatment-resistant depression, and post-traumatic stress disorder. Trial methodology, however, remains a fundamental source of uncertainty, and despite the popularity of...
The International Journal of Neuropsychopharmacology
September 9, 2026
J Vieira-Andrade, I Marques, M Brito
Abstract Background Serotonin 2A receptor (5-HT2AR) agonists play a crucial role in multiple cognitive processes, namely executive functions, learning and memory. Owing partly to this, psychedelics such as lysergic acid diethylamide (LSD), psilocybin, dimethyltryptamine (DMT), mescaline and ayahuasca might be valuable adjuvants in improving memory deficits and language impairment. Thanks to...